1 learning resource available for this topic
Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are two life-threatening acute complications of diabetes mellitus, both characterized by severe hyperglycemia but with distinct pathophysiological mechanisms. DKA typically occurs in type 1 diabetics with absolute insulin deficiency leading to ketosis, while HHS occurs in type 2 diabetics with relative insulin deficiency causing extreme dehydration without significant ketosis. Both conditions require immediate medical intervention but differ significantly in their presentation, laboratory findings, and treatment approaches.
DKA results from absolute insulin deficiency causing lipolysis and ketone body production, leading to metabolic acidosis with blood glucose typically 250-600 mg/dL and significant ketosis. HHS develops from relative insulin deficiency with enough residual insulin to prevent lipolysis but insufficient to control glucose, resulting in extreme hyperglycemia (>600 mg/dL) and severe dehydration without ketoacidosis. The osmotic diuresis in both conditions causes profound fluid and electrolyte losses, but HHS patients develop more severe dehydration due to the gradual onset and higher glucose levels.
Clinical differentiation relies on key laboratory markers: DKA presents with anion gap metabolic acidosis, positive ketones, and moderate hyperglycemia, while HHS shows minimal acidosis, absent or trace ketones, and extreme hyperglycemia with markedly elevated serum osmolality. DKA patients typically present acutely with nausea, vomiting, and altered mental status, whereas HHS develops gradually over days with progressive dehydration and neurological symptoms correlating with hyperosmolality. Treatment priorities differ with DKA requiring aggressive insulin therapy and ketosis reversal, while HHS emphasizes cautious fluid resuscitation and gradual glucose correction to prevent cerebral edema.